* Binge Eating Disorder (BED) has been fairly recently introduced into the Diagnostic and Statistical Manual 5 psychiatric classification and its severity criteria are still not well established. * Moreover, it remains unclear whether BED is associated with greater metabolic severity or more somatic comorbidities, especially in obesity. * Improved BED severity staging could lead to a better definition of management strategies and , therefore, facilitate screening and care. The investigators' hypothesis is that an improved assessment of the impulsivity-compulsivity spectrum, emotional regulation, attentional impairment and somatic or psychiatric comorbidities will result in a better distinction between the severe form of BED (e.g., highly impulsive and somatically complicated) from milder form (e.g., more compulsive and less somatically complicated).
Study Type
OBSERVATIONAL
Enrollment
200
(no intervention)
Centre d'expertise Poids, Image et Alimentation (CEPIA)
Québec, Canada
NOT_YET_RECRUITINGIUCPQ
Québec, Canada
RECRUITINGPhysical and psychological comorbidities
Number of current associated comorbidities to patient with and without BED
Time frame: Inclusion
Binge Eating Scale score
To assess binge eating severity based on the 16-item scale developed by Gormally et al in 1982
Time frame: Inclusion
Body Mass Index in kg.m-2
\[Anthropometric markers\] weight and height will be combined to report BMI in kg/m\^2
Time frame: Inclusion
Percentage of fat mass in %
\[Anthropometric markers\] Based on impedance data, percentage fat mass will be reported when available
Time frame: Inclusion
Waist and hip circumferences in cm
\[Anthropometric markers\] Waist, hip circumference and Waist-hip ratio will be reported in cm when available
Time frame: Inclusion
Triglycerides in mmol/L
Routine clinical biological markers; part of lipidic profile (when available)
Time frame: Inclusion
Cholesterol HDL and LDL in mmol/L
Routine clinical biological markers; part of lipidic profile (when available)
Time frame: Inclusion
Fasting blood glucose in mmol/L
Routine clinical biological markers, when available.
Time frame: Inclusion
Glycated hemoglobin (HbA1C) in %
Routine clinical biological markers, when available.
Time frame: Inclusion
Insulin in pmol/L
Routine clinical biological markers, when available.
Time frame: Inclusion
Visceral Adiposity Index
The Visceral Adiposity Index (VAI) is a sex-specific mathematical index, based on Waist Circumference (WC), Body Mass Index (BMI), triglycerides (TG) and HDL cholesterol (HDL) levels, indirectly expressing visceral adipose function and insulin sensitivity.
Time frame: Inclusion
UPPS-P Impulsive Behavior Scale short version, S-UPPS-P
To assess the Impulsivity-compulsivity spectrum
Time frame: Inclusion
Obsessive-Compulsive Inventory-Revised, OCI-R
To assess the Impulsivity-compulsivity spectrum
Time frame: Inclusion
Stop Signal Task
To assess the Impulsivity-compulsivity spectrum
Time frame: Inclusion
Difficulties in emotion regulation scale short form, DERS
To assess the emotion regulation spectrum
Time frame: Inclusion
Emotional Go / No-Go Task
To assess the emotion regulation spectrum
Time frame: Inclusion
Adult Attention Deficit Hyperactivity Disorder Self-Report Scale, ASRS
To assess attentional functions
Time frame: Inclusion
Integrated Visual and Auditory Continuous Performance Test, IVA-CPT
To assess attentional functions
Time frame: Inclusion
General Anxiety Disorder (GAD)-7
To assess anxiety disorders risk
Time frame: Inclusion
Patient Health Questionnaire (PHQ)-9
To assess depression disorder risk
Time frame: Inclusion
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.